XML 54 R32.htm IDEA: XBRL DOCUMENT v3.26.1
Note 7 - Share-based Compensation (Tables)
12 Months Ended
Dec. 31, 2025
Notes Tables  
Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]
   

Number

of shares

   

Weighted

average grant date

fair value

 
             

 $

 

Outstanding at December 31, 2023

    -       -  

Granted

    -       -  

Vested

    -       -  

Forfeited

    -       -  

Outstanding at December 31, 2024

    -       -  

Granted

    6,000       1.63  

Vested

    (3,000 )     1.63  

Forfeited

    -       -  

Outstanding at December 31, 2025

    3,000       1.63  

Expected to vest at December 31, 2025

    3,000       1.63  
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
   

Number

of options

   

Weighted

average

exercise

price

   

Weighted

average grant 

date fair value

   

 Weighted

average

remaining

contractual

term

   

Aggregate

intrinsic

value

 
           

$

   

$

   

Years

   

$

 

Outstanding at December 31, 2023

    1,865,226       6.46               7.66          

Granted

    838,939       3.02       2.53                  

Exercised

    (28,666 )     0.95       0.77               34  

Forfeited

    (149,845 )     7.50       5.73                  

Outstanding at December 31, 2024

    2,525,654       5.32               7.43       455  

Granted

    224,750       1.34       1.08                  

Forfeited

    (18,598 )     2.67       2.07                  

Outstanding at December 31, 2025

    2,731,806       5.01               6.58       514  

Exercisable as of December 31, 2025

    2,059,124       4.88               6.61       362  

Vested and expected to vest at December 31, 2025

    2,452,926       4.32               6.81       514  
    Number

of options

   

Weighted

average

exercise

price

   

Weighted

average grant

date fair value

   

Weighted

average

remaining

contractual

term

   

Aggregate

intrinsic

value

 
                           

Years

         

Outstanding at December 31, 2023

    1,257,000       0.50               8.82          

Granted

    651,333       0.60       0.26                  

Forfeited

    (9,500 )     0.50       0.32                  

Outstanding at December 31, 2024

    1,898,833       0.53               7.63       1,760  

Granted

    375,344       1.46       1.30                  

Exercised

    (77,250 )     1.12       0.84               26  

Forfeited

    (7,500 )     0.50       0.23                  

Outstanding at December 31, 2025

    2,189,427       0.67               7.05       2,230  

Exercisable as of December 31, 2025

    989,749       0.50               6.69       946  

Vested and expected to vest at December 31, 2025

    2,124,427       0.65               6.98       2,215  
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
   

For the year ended December 31,

 
    2024       

2025

 
                                 

Fair value of ordinary share

    0.90  

~

  3.60               1.34  

Risk-free interest rate

    3.84

%

~   4.52

%

    3.77 %

~

  4.03 %

Expected term (years)

    2.89  

~

  6.25       3.00  

~

  5.50  

Expected volatility

    110

%

~

  140

%

    105 %

~

  115 %

Expected dividend yield

            0 %             0 %

Contractual life (years)

    5  

~

  10       5  

~

  10  
   

For the year ended December 31,

 
   

2024

   

2025

 
                                 

Fair value of ordinary share

    0.19  

~

  1.46       1.46  

~

  1.69  

Risk-free interest rate

    3.51

%

~

  4.31

%

    3.81 %

~

  4.44 %

Expected term (years)

    3.75  

~

  6.25       5.50  

~

  10  

Expected volatility

    117.10

%

    141.40 %     114.02 %     126.34 %

Expected dividend yield

            0 %             0 %

Contractual life (years)

    5  

~

  10               10  
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
   

Year ended December 31,

 
   

2024

   

2025

 
   

$

   

$

 

Research and development

    63       106  

General and administrative

    2,000       390  
                 

Total

    2,063       496  
   

Year ended December 31,

 
   

2024

   

2025

 
   

$

   

$

 

Research and development

    50       29  

General and administrative

    142       196  
                 

Total

    192       225